{"title_page": "Nigeria/Economy", "text_new": "#REDIRECT [[Economy of Nigeria]]\n\n{{R from subpage}}\n", "text_old": "#REDIRECT [[Economy of Nigeria]]\n", "name_user": "1234qwer1234qwer4", "label": "safe", "comment": "\u2192\u200etop:R from subpage", "url_page": "//en.wikipedia.org/w/index.php?title=Nigeria/Economy&redirect=no"}
{"title_page": "Nigeria/Communications", "text_new": "#REDIRECT [[Telecommunications in Nigeria]]\n\n{{R from subpage}}\n", "text_old": "#REDIRECT [[Telecommunications in Nigeria]]\n", "name_user": "1234qwer1234qwer4", "label": "safe", "comment": "\u2192\u200etop:R from subpage", "url_page": "//en.wikipedia.org/w/index.php?title=Nigeria/Communications&redirect=no"}
{"title_page": "Niger/Transportation", "text_new": "#REDIRECT [[Transport in Niger]]\n\n{{R from subpage}}\n", "text_old": "#REDIRECT [[Transport in Niger]]\n", "name_user": "1234qwer1234qwer4", "label": "safe", "comment": "\u2192\u200etop:R from subpage", "url_page": "//en.wikipedia.org/w/index.php?title=Niger/Transportation&redirect=no"}
{"title_page": "Niger/Transnational issues", "text_new": "#REDIRECT [[Foreign_relations_of_Niger]]\n\n{{R from subpage}}\n", "text_old": "#REDIRECT [[Foreign_relations_of_Niger]]\n", "name_user": "1234qwer1234qwer4", "label": "safe", "comment": "\u2192\u200etop:R from subpage", "url_page": "//en.wikipedia.org/w/index.php?title=Niger/Transnational_issues&redirect=no"}
{"title_page": "Niger/People", "text_new": "#REDIRECT [[Demographics_of_Niger]]\n\n{{R from subpage}}\n", "text_old": "#REDIRECT [[Demographics_of_Niger]]\n", "name_user": "1234qwer1234qwer4", "label": "safe", "comment": "\u2192\u200etop:R from subpage", "url_page": "//en.wikipedia.org/w/index.php?title=Niger/People&redirect=no"}
{"title_page": "Spermatogonial stem cell", "text_new": "{{short description|Spermatogonium that does not differentiate into a spermatocyte}}\n{{Multiple issues|{{primary sources|date=January 2017}}{{technical|date=January 2017}}}}\n\n[[File:Spermatocytogenesis.png|thumb|The fates of spermatogonial stem cells: renewal or differentiation]]\nA '''spermatogonial stem cell''' ('''SSC'''), also known as a '''type A spermatogonium''', is a [[spermatogonium]] that does not differentiate into a [[spermatocyte]], a precursor of [[sperm]] cells. Instead, they continue dividing into other spermatogonia or remain dormant to maintain a reserve of spermatogonia. Type B spermatogonia, on the other hand, differentiate into spermatocytes, which in turn undergo [[meiosis]] to eventually form mature sperm cells.\n\n== Spermatogonial stem cells in the testis ==\n\nDuring foetal development, [[gonocyte]]s develop from primordial germ cells and following this SSCs develop from gonocytes in the testis.<ref name=\":0\">{{Cite journal|last=Phillips|first=Bart T.|last2=Gassei|first2=Kathrin|last3=Orwig|first3=Kyle E.|date=2010-05-27|title=Spermatogonial stem cell regulation and spermatogenesis|journal=Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|volume=365|issue=1546|pages=1663\u20131678|doi=10.1098/rstb.2010.0026|issn=1471-2970|pmc=2871929|pmid=20403877}}</ref> SSCs are the early precursor for [[Spermatozoon|spermatozoa]] and are responsible for the continuation of [[spermatogenesis]] in adult mammals. The stem cells are capable of dividing into more SSCs which is vital for maintaining the stem cell pool. Alternatively, they go on to differentiate into [[spermatocyte]]s, [[spermatid]]s and finally spermatozoa.\n\nOne SSC is the precursor for multiple spermatozoa and therefore SSCs are much less numerous in the testes than cells undergoing spermatogenesis.\n\n=== Nomenclature ===\n\n==== In humans ====\nUndifferentiated spermatogonia can be split into 2 groups; A Dark (A<sub>d</sub>)  and A Pale (A<sub>p</sub>)\n\nA<sub>d</sub> spermatogonia are reserve stem cells. These cells are capable of dividing to produce more SSCs but usually do not. A<sub>p</sub> spermatogonia are actively dividing to maintain the stem cell pool. B1-B4 spermatogonia encompass the differentiating spermatogonia and are no longer considered to be stem cells.\n\nMost research into SSCs has been carried out in rodents. The subtypes of spermatogonia differ between mice and humans.<ref name=\"Guo Hai Gong Li pp. 407\u2013413\">{{cite journal | last=Guo | first=Ying | last2=Hai | first2=Yanan | last3=Gong | first3=Yuehua | last4=Li | first4=Zheng | last5=He | first5=Zuping | title=Characterization, Isolation, and Culture of Mouse and Human Spermatogonial Stem Cells | journal=Journal of Cellular Physiology | volume=229 | issue=4 | date=2013-12-17 | issn=0021-9541 | doi=10.1002/jcp.24471 | pmid=24114612 | pages=407\u2013413}}</ref>\n\n==== In mice ====\nA Single (A<sub>s</sub>) spermatogonia are capable of creating 2 separate daughter SSCs when they divide or the daughter cells can join and form A Paired (A<sub>pr</sub>) spermatogonia.\n\nBoth A<sub>s</sub> and  A<sub>pr</sub> spermatogonia are undifferentiated. Chains of these cells form and are referred to as A Aligned (A<sub>al</sub>). A<sub>al</sub> spermatogonia differentiate and thus are no longer classed as stem cells. They go on to divide 6 times eventually forming B type spermatogonia.\n\n=== SSC Niche ===\nThe most important somatic cells that support regulation of SSCs are Sertoli cells. Various other somatic cells in the interstitial tissue support Sertoli cells such as [[Leydig cell]]s and [[peritubular myoid cells]] therefore  indirectly influencing SSCs and the location of their niche.<ref name=\":2\">{{Cite journal|last=de Rooij|first=Dirk G.|date=2009-08-01|title=The spermatogonial stem cell niche|journal=Microscopy Research and Technique|volume=72|issue=8|pages=580\u2013585|doi=10.1002/jemt.20699|issn=1097-0029|pmid=19263493}}</ref>\n\nSpermatogonia stem cells in mammals are found between the basal membrane of the seminiferous tubules and the [[Sertoli cell]]s. They remain here until the meiotic prophase stage of [[meiosis]]. Here the spermatocytes pass through the basal membrane via the sertoli cell barrier.\n\nSSCs stay within their niche where they are encouraged to self-renew. When they move past the basal membrane they differentiate due to cell signals.\n\n== Paracrine regulation of SSC self-renewal ==\nSelf-renewal of spermatogonial stem cells (SSCs) is regulated by local signals.<ref>{{Cite journal|last=Kubota|first=Hiroshi|last2=Avarbock|first2=Mary R.|last3=Brinster|first3=Ralph L.|date=2004-11-23|title=Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells|journal=Proceedings of the National Academy of Sciences of the United States of America|language=en|volume=101|issue=47|pages=16489\u201316494|doi=10.1073/pnas.0407063101|issn=0027-8424|pmc=534530|pmid=15520394}}</ref> Around 50% of the SSC population undergo self-renewal to maintain stem cell numbers, and the other 50% become committed progenitor cells that will differentiate into spermatozoa during spermatogenesis.<ref>{{Cite journal|last=de Rooij|first=Dirk G|last2=Grootegoed|first2=J Anton|date=1998-12-01|title=Spermatogonial stem cells|journal=Current Opinion in Cell Biology|volume=10|issue=6|pages=694\u2013701|doi=10.1016/S0955-0674(98)80109-9|pmid=9914171}}</ref> Cells present in the testes express molecules that play key roles in the regulation of SSC self-renewal. In mice, Sertoli cells have been shown to secrete Glial cell line-derived neurotrophic factor (GDNF) which has a stimulatory effect on stem cell self-renewal. This factor is thought to be expressed in the peritubular cells in human testes.<ref name=\":0\" /> Fibroblast growth factor (FGF2) is another molecule crucial for the regulation of stem cell renewal and is expressed in Sertoli cells, Leydig cells, and germ cells. FGF2 signalling interacts with GDNF to enhance proliferation rate.<ref name=\":0\" /> Chemokine (C-X-C motif) ligand 12 (CXCL12) signaling via its receptor C-X-C chemokine receptor type 4 (CXCR4) is also involved in regulation of SSC fate decisions.CXCL12 is found in Sertoli cells in the basement membrane of the seminiferous tubules in adult mouse testes, and its receptor is expressed in undifferentiated spermatogonial cells.<ref name=\":1\">{{Cite journal|last=Boitani|first=Carla|last2=Di Persio|first2=Sara|last3=Esposito|first3=Valentina|last4=Vicini|first4=Elena|date=2016-03-05|title=Spermatogonial cells: mouse, monkey and man comparison|journal=Seminars in Cell & Developmental Biology|doi=10.1016/j.semcdb.2016.03.002|issn=1096-3634|pmid=26957475|volume=59|pages=79\u201388}}</ref>\n\nGDNF and FGF2 are both required to activate the phosphoinositide 3-kinase (PI3K)-Akt pathway, and the mitogen-activated protein kinase/ERK1 kinase1 (MEK) pathway, which potentiates SSC proliferation and survival.<ref>{{Cite journal|last=Kanatsu-Shinohara|first=Mito|last2=Shinohara|first2=Takashi|date=2013-01-01|title=Spermatogonial Stem Cell Self-Renewal and Development|journal=Annual Review of Cell and Developmental Biology|volume=29|issue=1|pages=163\u2013187|doi=10.1146/annurev-cellbio-101512-122353|pmid=24099084}}</ref> CXCL12, FGF2, and GDNF all communicate via a network to mediate SSC functions.<ref name=\":1\" />\n\n== Differentiation ==\nSpermatogonial stem cells are the precursors to [[Spermatozoon|spermatozoa]], which are produced through a series of differentiation steps.<ref name=\":0\" /> This is the alternative SSC outcome to self-renewal. SSCs survive within microenvironments, termed niches, which provide extrinsic stimuli that drive stem cell differentiation or self-renewal.<ref>{{Cite journal|last=Oatley|first=Jon M.|last2=Brinster|first2=Ralph L.|date=2008-01-01|title=Regulation of spermatogonial stem cell self-renewal in mammals|journal=Annual Review of Cell and Developmental Biology|volume=24|pages=263\u2013286|doi=10.1146/annurev.cellbio.24.110707.175355|issn=1081-0706|pmc=4066667|pmid=18588486}}</ref> The SSC niche is found in the seminiferous epithelium of mammalian testis, and is primarily constituted of [[Sertoli cell|Sertoli]] and peritubular myoid cells.<ref name=\":1\" />\n\nThere are two primary differentiation stages, the first of which involves the transformation of A<sub>s</sub> (single) spermatogonia into daughter progeny A<sub>pr</sub> (paired) spermatogonia, which are predestined to differentiate. These can divide further to create A<sub>al</sub> (A-aligned) spermatogonia.<ref name=\":0\" />\n\nThe second step involves the production of differentiating A1 spermatogonia from A<sub>pr</sub> or A<sub>al</sub> spermatogonia. These A1 spermatogonia undergo a further five divisions to produce A2, A3, A4, intermediate and type B spermatogonia, which can enter [[Meiosis|meiosis I]].<ref name=\":0\" />\n\nIt takes around 64 days to produce mature [[Spermatozoon|spermatozoa]] from differentiating SSCs, and 100 million spermatozoa can be produced each day.<ref name=\":1\" />\n\nOne of the major known substances driving the differentiation of SSCs, and therefore the production of [[Spermatozoon|spermatozoa]], is [[Retinoic acid|Retinoic Acid]] (RA).<ref name=\":2\" /> There are theories supporting the hypotheses of both an indirect (via [[Sertoli cell]]s) or a direct pathway.<ref name=\":0\" />\n\nIt is thought that Sertoli cells produce RA through the conversion of circulating retinol to retinal and then finally to RA.<ref name=\":2\" />  Exposure to RA drives cellular differentiation into A1 spermatogonia and is implicated in further meiotic differentiation.<ref name=\":0\" /> As a result of differentiation, the genes required to maintain a SSC state are no longer expressed.<ref name=\":2\" />\n\nMale reproductive function declines with increasing age as indicated by decreased sperm quality and [[male infertility|fertility]].<ref name=\"pmid23443014\">{{cite journal |vauthors=Paul C, Robaire B |title=Ageing of the male germ line |journal=Nat Rev Urol |volume=10 |issue=4 |pages=227\u201334 |year=2013 |pmid=23443014 |doi=10.1038/nrurol.2013.18 |url=}}</ref>  As rats age, undifferentiated spermatogonial cells undergo numerous changes in gene expression.<ref name=\"pmid24227752\">{{cite journal |vauthors=Paul C, Nagano M, Robaire B |title=Aging results in molecular changes in an enriched population of undifferentiated rat spermatogonia |journal=Biol. Reprod. |volume=89 |issue=6 |pages=147 |year=2013 |pmid=24227752 |doi=10.1095/biolreprod.113.112995 |url=}}</ref>  These changes include upregulation of several genes involved in the [[DNA damage (naturally occurring)|DNA damage]] response.  This finding suggests that during [[aging]] there is an increase in DNA damage leading to an upregulation of DNA damage response proteins to help [[DNA repair|repair]] these damages.<ref name=\"pmid24227752\" />  Thus it appears that reproductive aging originates in undifferentiated spermatogenic cells.<ref name=\"pmid24227752\" />\n\n== Isolation and culture ==\nSSCs have the potential to become increasingly clinically relevant in treating sterility ([[In vitro spermatogenesis|''in vitro'' spermatogenesis]]) and preserving fertility prior to gonadotoxic treatments.<ref>{{Cite journal|last=Galuppo|first=Andrea Giannotti|date=2016-12-01|title=Spermatogonial stem cells as a therapeutic alternative for fertility preservation of prepubertal boys|journal=Einstein (S\u00e3o Paulo, Brazil)|volume=13|issue=4|pages=637\u2013639|doi=10.1590/S1679-45082015RB3456|issn=2317-6385|pmid=26761559|pmc=4878644}}</ref> To this aim, SSCs must be reliably isolated from testicular biopsies for the purposes of e.g. expansion and purification. Current protocols include magnetic-activated cell sorting (MACS) and [[Flow cytometry|fluorescence-activated cell sorting]] (FACS) based on positive SSC cellular markers such as CD90 <ref name=\":3\">{{Cite journal|last=Smith|first=James F.|last2=Yango|first2=Pamela|last3=Altman|first3=Eran|last4=Choudhry|first4=Shweta|last5=Poelzl|first5=Andrea|last6=Zamah|first6=Alberuni M.|last7=Rosen|first7=Mitchell|last8=Klatsky|first8=Peter C.|last9=Tran|first9=Nam D.|date=2014-09-01|title=Testicular niche required for human spermatogonial stem cell expansion|journal=Stem Cells Translational Medicine|volume=3|issue=9|pages=1043\u20131054|doi=10.5966/sctm.2014-0045|issn=2157-6564|pmid=25038247|pmc=4149303}}</ref> and FGFR3 <ref>{{Cite journal|last=von Kopylow|first=K.|last2=Schulze|first2=W.|last3=Salzbrunn|first3=A.|last4=Spiess|first4=A.-N.|date=2016-04-01|title=Isolation and gene expression analysis of single potential human spermatogonial stem cells|journal=Molecular Human Reproduction|volume=22|issue=4|pages=229\u2013239|doi=10.1093/molehr/gaw006|issn=1460-2407|pmid=26792870}}</ref> in combination with negative markers like CD45.<ref name=\":3\" /> The latter are particularly important in excluding malignant cells from cancer patients\u2019 biopsies.\n\nOnce isolated, SSC populations are cultured for the purposes of amplification, characterisation, line maintenance and potentially ''in vitro'' spermatogenesis or genomic editing.<ref>{{Cite journal|last=Mulder|first=Callista L.|last2=Zheng|first2=Yi|last3=Jan|first3=Sabrina Z.|last4=Struijk|first4=Robert B.|last5=Repping|first5=Sjoerd|last6=Hamer|first6=Geert|last7=van Pelt|first7=Ans M. M.|date=2016-09-01|title=Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseases|journal=Human Reproduction Update|volume=22|issue=5|pages=561\u2013573|doi=10.1093/humupd/dmw017|issn=1460-2369|pmid=27240817|pmc=5001497}}</ref> The main challenges to SSC culturing are the interactions between media substances and the epigenetic makeup that underlies pluripotency and can affect future offspring. Short-term ''in vitro'' propagation of these cells has been carried out in Stem-Pro 34 media supplemented by growth factors.<ref>{{Cite journal|last=Akhondi|first=Mohammad Mehdi|last2=Mohazzab|first2=Arash|last3=Jeddi-Tehrani|first3=Mahmood|last4=Sadeghi|first4=Mohammad Reza|last5=Eidi|first5=Akram|last6=Khodadadi|first6=Abbas|last7=Piravar|first7=Zeinab|date=2013-07-01|title=Propagation of human germ stem cells in long-term culture|journal=Iranian Journal of Reproductive Medicine|volume=11|issue=7|pages=551\u2013558|issn=1680-6433|pmid=24639790|pmc=3941344}}</ref> Long-term culture of human SSCs is not established yet, however one group reports successful proliferation in feeder cell-free media supplied with growth factors and hydrogel.<ref>{{Cite journal|last=Guo|first=Ying|last2=Liu|first2=Linhong|last3=Sun|first3=Min|last4=Hai|first4=Yanan|last5=Li|first5=Zheng|last6=He|first6=Zuping|date=2015-08-01|title=Expansion and long-term culture of human spermatogonial stem cells via the activation of SMAD3 and AKT pathways|journal=Experimental Biology and Medicine (Maywood, N.J.)|volume=240|issue=8|pages=1112\u20131122|doi=10.1177/1535370215590822|issn=1535-3699|pmid=26088866|pmc=4935290}}</ref>\n\n== Transplantation ==\nThe first successful SSC transplantation was described in mice in 1994 whereby the procedure restored spermatogenesis fully in an otherwise infertile mouse.<ref>{{Cite journal|last=Brinster|first=R. L.|last2=Avarbock|first2=M. R.|date=1994-11-22|title=Germline transmission of donor haplotype following spermatogonial transplantation|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=91|issue=24|pages=11303\u201311307|issn=0027-8424|pmc=45219|pmid=7972054|doi=10.1073/pnas.91.24.11303}}</ref> These mice were then able to produce viable offspring which opened new exciting doors for future potential therapies in humans.\n\nAs cancer treatments are not cancer cell-specific and are often gonadotoxic (toxic to the ovaries and the testes), children usually face infertility as a consequence of treatment as there is no established way to preserve their fertility yet, especially in prepubertal boys. Infertility after cancer treatment depends on the type and dosage of treatment but can vary from 17% to 82% of patients.<ref>{{Cite journal|last=Struijk|first=Robert B.|last2=Mulder|first2=Callista L.|last3=van der Veen|first3=Fulco|last4=van Pelt|first4=Ans M. M.|last5=Repping|first5=Sjoerd|date=2013-01-01|title=Restoring Fertility in Sterile Childhood Cancer Survivors by Autotransplanting Spermatogonial Stem Cells: Are We There Yet?|journal=BioMed Research International|volume=2013|doi=10.1155/2013/903142|issn=2314-6133|pmc=3581117|pmid=23509797|pages=903142}}</ref> Spermatogonial stem cell therapy (SSCT) has been proposed as a potential method to restore fertility in such cancer survivors who desire to have children later in life. The method has been tested in numerous animal models including non-human primates; Hermann ''et al''.<ref>{{Cite journal|last=Hermann|first=Brian P.|last2=Sukhwani|first2=Meena|last3=Winkler|first3=Felicity|last4=Pascarella|first4=Julia N.|last5=Peters|first5=Karen A.|last6=Sheng|first6=Yi|last7=Valli|first7=Hanna|last8=Rodriguez|first8=Mario|last9=Ezzelarab|first9=Mohamed|date=2012-11-02|title=Spermatogonial stem cell transplantation into Rhesus testes regenerates spermatogenesis producing functional sperm|journal=Cell Stem Cell|volume=11|issue=5|pages=715\u2013726|doi=10.1016/j.stem.2012.07.017|issn=1934-5909|pmc=3580057|pmid=23122294}}</ref>  took out and isolated SSCs from prepubertal and adult rhesus macaques before treating them with busulfan (an [[alkylation|alkylating agent]] used in chemotherapy). SSCs were then injected back into the rete testis of the same animal that they were taken from ~10\u201312 weeks after treatment; and spermatogenesis was observed in almost all recipients (16/17). However, these SSCs were difficult to detect which is why further analysis of the ability of descendant sperm to fertilise could not be determined. The viability of embryos fertilised by donor sperm after SSC transplantation needs to be evaluated to truly determine the usefulness of this technique.\n\nRecently, SSC transplantation has also been proposed as a potential method for conservation of endangered species through [[Xenotransplantation|xenogeneic transplantation]]. Roe ''et al.'' <ref>{{Cite journal|last=Roe|first=Mandi|last2=McDonald|first2=Nastassja|last3=Durrant|first3=Barbara|last4=Jensen|first4=Thomas|date=2013-05-01|title=Xenogeneic transfer of adult quail (Coturnix coturnix) spermatogonial stem cells to embryonic chicken (Gallus gallus) hosts: a model for avian conservation|journal=Biology of Reproduction|volume=88|issue=5|pages=129|doi=10.1095/biolreprod.112.105189|issn=1529-7268|pmc=4013913|pmid=23575150}}</ref> suggested that the reproductive lifespan of such species could be extended by transplanting their germ cells into a domestic host. In their study, they used the quail as a model for an exotic species and transplanted SSCs into chicken embryos which successfully colonized the gonadal ridge of the host embryo. This allows the isolation of mature sperm later on in development from the host even after the donor has deceased which can be used in future fertilization and potentially more successful conservation.<ref>\n{{cite journal |authors=Mahla RS| title = Stem cells application in regenerative medicine and disease threpeutics | journal = International Journal of Cell Biology  | volume = 2016 | issue = 7 | pages = 1\u201324 | year = 2016 | pmid = 27516776 | pmc = 4969512 | doi = 10.1155/2016/6940283 }}</ref>\n\n== References ==\n{{Reflist}}\n\n[[Category:Stem cells]]\n", "text_old": "{{short description|Spermatogonium that does not differentiate into a spermatocyte}}\n{{Multiple issues|{{primary sources|date=January 2017}}{{technical|date=January 2017}}}}\n\n[[File:Spermatocytogenesis.png|thumb|The fates of spermatogonial stem cells: renewal or differentiation]]\nA '''spermatogonial stem cell''' ('''SSC'''), also known as a '''type A spermatogonium''', is a [[spermatogonium]] that does not differentiate into a [[spermatocyte]], a precursor of [[sperm]] cells. Instead, they continue dividing into other spermatogonia or remain dormant to maintain a reserve of spermatogonia. Type B spermatogonia, on the other hand, differentiate into spermatocytes, which in turn undergo [[meiosis]] to eventually form mature sperm cells.\n\n== Spermatogonial stem cells in the testis ==\n\nDuring foetal development, [[gonocyte]]s develop from primordial germ cells and following this SSCs develop from gonocytes in the testis.<ref name=\":0\">{{Cite journal|last=Phillips|first=Bart T.|last2=Gassei|first2=Kathrin|last3=Orwig|first3=Kyle E.|date=2010-05-27|title=Spermatogonial stem cell regulation and spermatogenesis|journal=Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|volume=365|issue=1546|pages=1663\u20131678|doi=10.1098/rstb.2010.0026|issn=1471-2970|pmc=2871929|pmid=20403877}}</ref> SSCs are the early precursor for [[Spermatozoon|spermatozoa]] and are responsible for the continuation of [[spermatogenesis]] in adult mammals. The stem cells are capable of dividing into more SSCs which is vital for maintaining the stem cell pool. Alternatively, they go on to differentiate into [[spermatocyte]]s, [[spermatid]]s and finally spermatozoa.\n\nOne SSC is the precursor for multiple spermatozoa and therefore SSCs are much less numerous in the testes than cells undergoing spermatogenesis.\n\n=== Nomenclature ===\n\n==== In humans ====\nUndifferentiated spermatogonia can be split into 2 groups; A Dark (A<sub>d</sub>)  and A Pale (A<sub>p</sub>)\n\nA<sub>d</sub> spermatogonia are reserve stem cells. These cells are capable of dividing to produce more SSCs but usually do not. A<sub>p</sub> spermatogonia are actively dividing to maintain the stem cell pool. B1-B4 spermatogonia encompass the differentiating spermatogonia and are no longer considered to be stem cells.\n\nMost research into SSCs has been carried out in rodents. The subtypes of spermatogonia differ between mice and humans.<ref name=\"Guo Hai Gong Li pp. 407\u2013413\">{{cite journal | last=Guo | first=Ying | last2=Hai | first2=Yanan | last3=Gong | first3=Yuehua | last4=Li | first4=Zheng | last5=He | first5=Zuping | title=Characterization, Isolation, and Culture of Mouse and Human Spermatogonial Stem Cells | journal=Journal of Cellular Physiology | volume=229 | issue=4 | date=2013-12-17 | issn=0021-9541 | doi=10.1002/jcp.24471 | pmid=24114612 | pages=407\u2013413}}</ref>\n\n==== In mice ====\nA Single (A<sub>s</sub>) spermatogonia are capable of creating 2 separate daughter SSCs when they divide or the daughter cells can join and form A Paired (A<sub>pr</sub>) spermatogonia.\n\nBoth A<sub>s</sub> and  A<sub>pr</sub> spermatogonia are undifferentiated. Chains of these cells form and are referred to as A Aligned (A<sub>al</sub>). A<sub>al</sub> spermatogonia differentiate and thus are no longer classed as stem cells. They go on to divide 6 times eventually forming B type spermatogonia.\n\n=== SSC Niche ===\nThe most important somatic cells that support regulation of SSCs are Sertoli cells. Various other somatic cells in the interstitial tissue support Sertoli cells such as [[Leydig cell]]s and [[peritubular myoid cells]] therefore  indirectly influencing SSCs and the location of their niche.<ref name=\":2\">{{Cite journal|last=de Rooij|first=Dirk G.|date=2009-08-01|title=The spermatogonial stem cell niche|journal=Microscopy Research and Technique|volume=72|issue=8|pages=580\u2013585|doi=10.1002/jemt.20699|issn=1097-0029|pmid=19263493}}</ref>\n\nSpermatogonia stem cells in mammals are found between the basal membrane of the seminiferous tubules and the [[Sertoli cell]]s. They remain here until the meiotic prophase stage of [[meiosis]]. Here the spermatocytes pass through the basal membrane via the sertoli cell barrier.\n\nSSCs stay within their niche where they are encouraged to self-renew. When they move past the basal membrane they differentiate due to cell signals.\n\n== Paracrine regulation of SSC self-renewal ==\nSelf-renewal of spermatogonial stem cells (SSCs) is regulated by local signals.<ref>{{Cite journal|last=Kubota|first=Hiroshi|last2=Avarbock|first2=Mary R.|last3=Brinster|first3=Ralph L.|date=2004-11-23|title=Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells|journal=Proceedings of the National Academy of Sciences of the United States of America|language=en|volume=101|issue=47|pages=16489\u201316494|doi=10.1073/pnas.0407063101|issn=0027-8424|pmc=534530|pmid=15520394}}</ref> Around 50% of the SSC population undergo self-renewal to maintain stem cell numbers, and the other 50% become committed progenitor cells that will differentiate into spermatozoa during spermatogenesis.<ref>{{Cite journal|last=de Rooij|first=Dirk G|last2=Grootegoed|first2=J Anton|date=1998-12-01|title=Spermatogonial stem cells|journal=Current Opinion in Cell Biology|volume=10|issue=6|pages=694\u2013701|doi=10.1016/S0955-0674(98)80109-9|pmid=9914171}}</ref> Cells present in the testes express molecules that play key roles in the regulation of SSC self-renewal. In mice, Sertoli cells have been shown to secrete Glial cell line-derived neurotrophic factor (GDNF) which has a stimulatory effect on stem cell self-renewal. This factor is thought to be expressed in the peritubular cells in human testes.<ref name=\":0\" /> Fibroblast growth factor (FGF2) is another molecule crucial for the regulation of stem cell renewal and is expressed in Sertoli cells, Leydig cells, and germ cells. FGF2 signalling interacts with GDNF to enhance proliferation rate.<ref name=\":0\" /> Chemokine (C-X-C motif) ligand 12 (CXCL12) signaling via its receptor C-X-C chemokine receptor type 4 (CXCR4) is also involved in regulation of SSC fate decisions.CXCL12 is found in Sertoli cells in the basement membrane of the seminiferous tubules in adult mouse testes, and its receptor is expressed in undifferentiated spermatogonial cells.<ref name=\":1\">{{Cite journal|last=Boitani|first=Carla|last2=Di Persio|first2=Sara|last3=Esposito|first3=Valentina|last4=Vicini|first4=Elena|date=2016-03-05|title=Spermatogonial cells: mouse, monkey and man comparison|journal=Seminars in Cell & Developmental Biology|doi=10.1016/j.semcdb.2016.03.002|issn=1096-3634|pmid=26957475|volume=59|pages=79\u201388}}</ref>\n\nGDNF and FGF2 are both required to activate the phosphoinositide 3-kinase (PI3K)-Akt pathway, and the mitogen-activated protein kinase/ERK1 kinase1 (MEK) pathway, which potentiates SSC proliferation and survival.<ref>{{Cite journal|last=Kanatsu-Shinohara|first=Mito|last2=Shinohara|first2=Takashi|date=2013-01-01|title=Spermatogonial Stem Cell Self-Renewal and Development|journal=Annual Review of Cell and Developmental Biology|volume=29|issue=1|pages=163\u2013187|doi=10.1146/annurev-cellbio-101512-122353|pmid=24099084}}</ref> CXCL12, FGF2, and GDNF all communicate via a network to mediate SSC functions.<ref name=\":1\" />\n\n== Differentiation ==\nSpermatogonial stem cells are the precursors to [[Spermatozoon|spermatozoa]], which are produced through a series of differentiation steps.<ref name=\":0\" /> This is the alternative SSC outcome to self-renewal. SSCs survive within microenvironments, termed niches, which provide extrinsic stimuli that drive stem cell differentiation or self-renewal.<ref>{{Cite journal|last=Oatley|first=Jon M.|last2=Brinster|first2=Ralph L.|date=2008-01-01|title=Regulation of spermatogonial stem cell self-renewal in mammals|journal=Annual Review of Cell and Developmental Biology|volume=24|pages=263\u2013286|doi=10.1146/annurev.cellbio.24.110707.175355|issn=1081-0706|pmc=4066667|pmid=18588486}}</ref> The SSC niche is found in the seminiferous epithelium of mammalian testis, and is primarily constituted of [[Sertoli cell|Sertoli]] and peritubular myoid cells.<ref name=\":1\" />\n\nThere are two primary differentiation stages, the first of which involves the transformation of A<sub>s</sub> (single) spermatogonia into daughter progeny A<sub>pr</sub> (paired) spermatogonia, which are predestined to differentiate. These can divide further to create A<sub>al</sub> (A-aligned) spermatogonia.<ref name=\":0\" />\n\nThe second step involves the production of differentiating A1 spermatogonia from A<sub>pr</sub> or A<sub>al</sub> spermatogonia. These A1 spermatogonia undergo a further five divisions to produce A2, A3, A4, intermediate and type B spermatogonia, which can enter [[Meiosis|meiosis I]].<ref name=\":0\" />\n\nIt takes around 64 days to produce mature [[Spermatozoon|spermatozoa]] from differentiating SSCs, and 100 million spermatozoa can be produced each day.<ref name=\":1\" />\n\nOne of the major known substances driving the differentiation of SSCs, and therefore the production of [[Spermatozoon|spermatozoa]], is [[Retinoic acid|Retinoic Acid]] (RA).<ref name=\":2\" /> There are theories supporting the hypotheses of both an indirect (via [[Sertoli cell]]s) or a direct pathway.<ref name=\":0\" />\n\nIt is thought that Sertoli cells produce RA through the conversion of circulating retinol to retinal and then finally to RA.<ref name=\":2\" />  Exposure to RA drives cellular differentiation into A1 spermatogonia and is implicated in further meiotic differentiation.<ref name=\":0\" /> As a result of differentiation, the genes required to maintain a SSC state are no longer expressed.<ref name=\":2\" />\n\nMale reproductive function declines with increasing age as indicated by decreased sperm quality and [[male infertility|fertility]].<ref name=\"pmid23443014\">{{cite journal |vauthors=Paul C, Robaire B |title=Ageing of the male germ line |journal=Nat Rev Urol |volume=10 |issue=4 |pages=227\u201334 |year=2013 |pmid=23443014 |doi=10.1038/nrurol.2013.18 |url=}}</ref>  As rats age, undifferentiated spermatogonial cells undergo numerous changes in gene expression.<ref name=\"pmid24227752\">{{cite journal |vauthors=Paul C, Nagano M, Robaire B |title=Aging results in molecular changes in an enriched population of undifferentiated rat spermatogonia |journal=Biol. Reprod. |volume=89 |issue=6 |pages=147 |year=2013 |pmid=24227752 |doi=10.1095/biolreprod.113.112995 |url=}}</ref>  These changes include upregulation of several genes involved in the [[DNA damage (naturally occurring)|DNA damage]] response.  This finding suggests that during [[aging]] there is an increase in DNA damage leading to an upregulation of DNA damage response proteins to help [[DNA repair|repair]] these damages.<ref name=\"pmid24227752\" />  Thus it appears that reproductive aging originates in undifferentiated spermatogenic cells.<ref name=\"pmid24227752\" />\n\n== Isolation and culture ==\nSSCs have the potential to become increasingly clinically relevant in treating sterility ([[In vitro spermatogenesis|''in vitro'' spermatogenesis]]) and preserving fertility prior to gonadotoxic treatments.<ref>{{Cite journal|last=Galuppo|first=Andrea Giannotti|date=2016-12-01|title=Spermatogonial stem cells as a therapeutic alternative for fertility preservation of prepubertal boys|journal=Einstein (S\u00e3o Paulo, Brazil)|volume=13|issue=4|pages=637\u2013639|doi=10.1590/S1679-45082015RB3456|issn=2317-6385|pmid=26761559|pmc=4878644}}</ref> To this aim, SSCs must be reliably isolated from testicular biopsies for the purposes of e.g. expansion and purification. Current protocols include magnetic-activated cell sorting (MACS) and [[Flow cytometry|fluorescence-activated cell sorting]] (FACS) based on positive SSC cellular markers such as CD90 <ref name=\":3\">{{Cite journal|last=Smith|first=James F.|last2=Yango|first2=Pamela|last3=Altman|first3=Eran|last4=Choudhry|first4=Shweta|last5=Poelzl|first5=Andrea|last6=Zamah|first6=Alberuni M.|last7=Rosen|first7=Mitchell|last8=Klatsky|first8=Peter C.|last9=Tran|first9=Nam D.|date=2014-09-01|title=Testicular niche required for human spermatogonial stem cell expansion|journal=Stem Cells Translational Medicine|volume=3|issue=9|pages=1043\u20131054|doi=10.5966/sctm.2014-0045|issn=2157-6564|pmid=25038247|pmc=4149303}}</ref> and FGFR3 <ref>{{Cite journal|last=von Kopylow|first=K.|last2=Schulze|first2=W.|last3=Salzbrunn|first3=A.|last4=Spiess|first4=A.-N.|date=2016-04-01|title=Isolation and gene expression analysis of single potential human spermatogonial stem cells|journal=Molecular Human Reproduction|volume=22|issue=4|pages=229\u2013239|doi=10.1093/molehr/gaw006|issn=1460-2407|pmid=26792870}}</ref> in combination with negative markers like CD45.<ref name=\":3\" /> The latter are particularly important in excluding malignant cells from cancer patients\u2019 biopsies.\n\nOnce isolated, SSC populations are cultured for the purposes of amplification, characterisation, line maintenance and potentially ''in vitro'' spermatogenesis or genomic editing.<ref>{{Cite journal|last=Mulder|first=Callista L.|last2=Zheng|first2=Yi|last3=Jan|first3=Sabrina Z.|last4=Struijk|first4=Robert B.|last5=Repping|first5=Sjoerd|last6=Hamer|first6=Geert|last7=van Pelt|first7=Ans M. M.|date=2016-09-01|title=Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseases|journal=Human Reproduction Update|volume=22|issue=5|pages=561\u2013573|doi=10.1093/humupd/dmw017|issn=1460-2369|pmid=27240817|pmc=5001497}}</ref> The main challenges to SSC culturing are the interactions between media substances and the epigenetic makeup that underlies pluripotency and can affect future offspring. Short-term ''in vitro'' propagation of these cells has been carried out in Stem-Pro 34 media supplemented by growth factors.<ref>{{Cite journal|last=Akhondi|first=Mohammad Mehdi|last2=Mohazzab|first2=Arash|last3=Jeddi-Tehrani|first3=Mahmood|last4=Sadeghi|first4=Mohammad Reza|last5=Eidi|first5=Akram|last6=Khodadadi|first6=Abbas|last7=Piravar|first7=Zeinab|date=2013-07-01|title=Propagation of human germ stem cells in long-term culture|journal=Iranian Journal of Reproductive Medicine|volume=11|issue=7|pages=551\u2013558|issn=1680-6433|pmid=24639790|pmc=3941344}}</ref> Long-term culture of human SSCs is not established yet, however one group reports successful proliferation in feeder cell-free media supplied with growth factors and hydrogel.<ref>{{Cite journal|last=Guo|first=Ying|last2=Liu|first2=Linhong|last3=Sun|first3=Min|last4=Hai|first4=Yanan|last5=Li|first5=Zheng|last6=He|first6=Zuping|date=2015-08-01|title=Expansion and long-term culture of human spermatogonial stem cells via the activation of SMAD3 and AKT pathways|journal=Experimental Biology and Medicine (Maywood, N.J.)|volume=240|issue=8|pages=1112\u20131122|doi=10.1177/1535370215590822|issn=1535-3699|pmid=26088866|pmc=4935290}}</ref>\n\n== Transplantation ==\nThe first successful SSC transplantation was described in mice in 1994 whereby the procedure restored spermatogenesis fully in an otherwise infertile mouse.<ref>{{Cite journal|last=Brinster|first=R. L.|last2=Avarbock|first2=M. R.|date=1994-11-22|title=Germline transmission of donor haplotype following spermatogonial transplantation|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=91|issue=24|pages=11303\u201311307|issn=0027-8424|pmc=45219|pmid=7972054|doi=10.1073/pnas.91.24.11303}}</ref> These mice were then able to produce viable offspring which opened new exciting doors for future potential therapies in humans.\n\nAs cancer treatments are not cancer cell-specific and are often gonadotoxic (toxic to the ovaries and the testes), children usually face infertility as a consequence of treatment as there is no established way to preserve their fertility yet, especially in prepubertal boys. Infertility after cancer treatment depends on the type and dosage of treatment but can vary from 17% to 82% of patients.<ref>{{Cite journal|last=Struijk|first=Robert B.|last2=Mulder|first2=Callista L.|last3=van der Veen|first3=Fulco|last4=van Pelt|first4=Ans M. M.|last5=Repping|first5=Sjoerd|date=2013-01-01|title=Restoring Fertility in Sterile Childhood Cancer Survivors by Autotransplanting Spermatogonial Stem Cells: Are We There Yet?|journal=BioMed Research International|volume=2013|doi=10.1155/2013/903142|issn=2314-6133|pmc=3581117|pmid=23509797|pages=903142}}</ref> Spermatogonial stem cell therapy (SSCT) has been proposed as a potential method to restore fertility in such cancer survivors who desire to have children later in life. The method has been tested in numerous animal models including non-human primates; Hermann ''et al''.<ref>{{Cite journal|last=Hermann|first=Brian P.|last2=Sukhwani|first2=Meena|last3=Winkler|first3=Felicity|last4=Pascarella|first4=Julia N.|last5=Peters|first5=Karen A.|last6=Sheng|first6=Yi|last7=Valli|first7=Hanna|last8=Rodriguez|first8=Mario|last9=Ezzelarab|first9=Mohamed|date=2012-11-02|title=Spermatogonial stem cell transplantation into Rhesus testes regenerates spermatogenesis producing functional sperm|journal=Cell Stem Cell|volume=11|issue=5|pages=715\u2013726|doi=10.1016/j.stem.2012.07.017|issn=1934-5909|pmc=3580057|pmid=23122294}}</ref>  took out and isolated SSCs from prepubertal and adult rhesus macaques before treating them with busulfan (an alkylating agent used in chemotherapy). SSCs were then injected back into the rete testis of the same animal that they were taken from ~10\u201312 weeks after treatment; and spermatogenesis was observed in almost all recipients (16/17). However, these SSCs were difficult to detect which is why further analysis of the ability of descendant sperm to fertilise could not be determined. The viability of embryos fertilised by donor sperm after SSC transplantation needs to be evaluated to truly determine the usefulness of this technique.\n\nRecently, SSC transplantation has also been proposed as a potential method for conservation of endangered species through [[Xenotransplantation|xenogeneic transplantation]]. Roe ''et al.'' <ref>{{Cite journal|last=Roe|first=Mandi|last2=McDonald|first2=Nastassja|last3=Durrant|first3=Barbara|last4=Jensen|first4=Thomas|date=2013-05-01|title=Xenogeneic transfer of adult quail (Coturnix coturnix) spermatogonial stem cells to embryonic chicken (Gallus gallus) hosts: a model for avian conservation|journal=Biology of Reproduction|volume=88|issue=5|pages=129|doi=10.1095/biolreprod.112.105189|issn=1529-7268|pmc=4013913|pmid=23575150}}</ref> suggested that the reproductive lifespan of such species could be extended by transplanting their germ cells into a domestic host. In their study, they used the quail as a model for an exotic species and transplanted SSCs into chicken embryos which successfully colonized the gonadal ridge of the host embryo. This allows the isolation of mature sperm later on in development from the host even after the donor has deceased which can be used in future fertilization and potentially more successful conservation.<ref>\n{{cite journal |authors=Mahla RS| title = Stem cells application in regenerative medicine and disease threpeutics | journal = International Journal of Cell Biology  | volume = 2016 | issue = 7 | pages = 1\u201324 | year = 2016 | pmid = 27516776 | pmc = 4969512 | doi = 10.1155/2016/6940283 }}</ref>\n\n== References ==\n{{Reflist}}\n\n[[Category:Stem cells]]\n", "name_user": "Akrasia25", "label": "safe", "comment": "linkalkylating agentusingFind link", "url_page": "//en.wikipedia.org/wiki/Spermatogonial_stem_cell"}
{"title_page": "Niger/Military", "text_new": "#REDIRECT [[Niger Armed Forces]]\n\n{{R from subpage}}\n", "text_old": "#REDIRECT [[Niger Armed Forces]]\n", "name_user": "1234qwer1234qwer4", "label": "safe", "comment": "\u2192\u200etop:R from subpage", "url_page": "//en.wikipedia.org/w/index.php?title=Niger/Military&redirect=no"}
